Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4750141
Max Phase: Preclinical
Molecular Formula: C29H36N2O6
Molecular Weight: 508.62
Molecule Type: Unknown
Associated Items:
ID: ALA4750141
Max Phase: Preclinical
Molecular Formula: C29H36N2O6
Molecular Weight: 508.62
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)[C@H]1[C@@H]2C=C[C@@H]3[C@H]4C/C=C\C(=O)NCC[C@H](O)[C@@H]5NC(=O)C(=C5O)C(=O)/C=C/[C@@H]4C[C@@H]3[C@H]2C[C@H]1C
Standard InChI: InChI=1S/C29H36N2O6/c1-14-12-20-19(25(14)15(2)32)8-7-18-17-4-3-5-24(35)30-11-10-23(34)27-28(36)26(29(37)31-27)22(33)9-6-16(17)13-21(18)20/h3,5-9,14,16-21,23,25,27,34,36H,4,10-13H2,1-2H3,(H,30,35)(H,31,37)/b5-3-,9-6+/t14-,16-,17+,18-,19-,20+,21+,23+,25+,27+/m1/s1
Standard InChI Key: NFOOLVHNHWLUNO-KSJIDVQUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 508.62 | Molecular Weight (Monoisotopic): 508.2573 | AlogP: 2.17 | #Rotatable Bonds: 1 |
Polar Surface Area: 132.80 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.43 | CX Basic pKa: | CX LogP: 1.18 | CX LogD: -2.21 |
Aromatic Rings: 0 | Heavy Atoms: 37 | QED Weighted: 0.32 | Np Likeness Score: 1.63 |
1. Jiao YJ,Liu Y,Wang HX,Zhu DY,Shen YM,Li YY. (2020) Expression of the Clifednamide Biosynthetic Pathway in Streptomyces Generates 27,28-seco-Derivatives., 83 (9.0): [PMID:32915576] [10.1021/acs.jnatprod.0c00900] |
Source(1):